Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: PLC Systems

This article was originally published in The Gray Sheet

Executive Summary

PLC Systems: Plans first quarter 1996 submission of an investigational device exemption to examine the effect of transmyocardial revascularization (TMR) with its Heart Laser device on heart transplant patients. A second IDE submission to perform TMR using a thoracoscope is planned within the same time frame. The firm is awaiting approval for trials using the device in conjunction with coronary bypass. Current studies are comparing use of the device to repeat bypass. A premarket approval application was submitted in April 1995 for use of the device in treating coronary disease in patients without alternative treatment options...
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT005333

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel